Communicable E33: Ethics in infectious diseases
Ethics in the field of infectious disease can be a delicate interplay between treating the individual patient and protecting the collective health of a society. Sometimes these two mandates go hand in...
10 Aug 202536min
Communicable E32: Fluoroquinolones - to heal or harm?
Fluoroquinolones (FQs) are valuable given their broad-spectrum activity against Gram-positive and Gram-negative bacteria and their high penetration into various tissues. Yet FQs have also caused conce...
27 Jul 202555min
Communicable E31: Climate change and fungal spread
The adaptability of fungi to warmer temperatures is an obvious consequence of climate change. Perhaps less obvious is the role climate change has played on fungal pathogens emerging as a global health...
13 Jul 202551min
Communicable E30: WHO's first-ever guideline on meningitis
Meningitis remains a major global health threat, with an estimated 2.5 million cases each year; of these, one in six results in death and one in five in long-term disabilities. Although meningitis “ca...
29 Jun 20251h
Communicable E29: Bacterial vaginosis & male partners
Bacterial vaginosis (BV) was long considered not to be a sexually transmitted infection (STI), and treatment was only for women to bear. That was the convention at least until Catriona Bradshaw and he...
15 Jun 202559min
Communicable E28: Late-breaker trials at ESCMID Global: Should they change your practice? - part 2
Editors of CMI Comms, Josh Davis, Erin McCreary and Emily McDonald return for round 2 taking turns to summarise and discuss late-breaker trials presented at ESCMID Global 2025 in Vienna, and whether o...
1 Jun 202547min
Communicable E27: Late-breaker trials at ESCMID Global: Should they change your practice? - part 1
This episode of Communicable takes on a special format where editors of CMI Comms, Marc Bonten, Josh Davis, Erin McCreary, Emily McDonald, all clinical trialists in their own right, take turns to summ...
18 Mai 202553min
Communicable E26: SNAP out of it: Rethinking anti-staphylococcal penicillins for S. aureus bacteremia - the SNAP trial PSSA/MSSA results
In this first-ever collaboration between Communicable and Breakpoints, the podcast of the US Society of Infectious Diseases Pharmacists, hosts Angela Huttner (Geneva, Switzerland) and Erin McCreary (P...
4 Mai 20251h 10min
